Not a few baby boomers are probably scratching their heads over the current “psychedelic renaissance,” wondering how and when those dangerous drugs that can fry your brain sunny side up suddenly became a promising new “miracle cure” for depression and PTSD. As a journalist of a certain age, I have been watching, fascinated, as psychedelic … Read More »
A Mid-Life Trip
I recently traveled to New York to attend the Horizons conference on psychedelics – now in its 15th year. Particularly exciting for me was the opportunity to hear Dr. Anthony Bossis of NYU talk about psychedelics in palliative care – a topic that has intrigued me since reading Michael Pollan’s How To Change Your Mind in … Read More »
Can Psychedelics Help Us Face our Fear of Death
Happy Holidays and New Year As my work as a journalist wanes, eclipsed by other writing projects, I’m happy to share my my most recent article, in DoubleBlind magazine, about a topic I am fascinated with. Anyone with thoughts to share, I’m happy to hear! For all its inevitability, death in our society is still … Read More »
Notes From The Cutting Edge: Israeli Researcher Dedi Meiri On Cannabis, Alzheimer’s And Dementia
I recently listened to a webinar where David (Dedi) Meiri spoke about the cannabis research in his lab at the Technion-Israel Institute of Technology. Meiri is best known for his work matching specific components of cannabis to affect different types of cancer. But when the interviewer asked the Israeli researcher which areas of medicine he thought cannabis … Read More »
MAPS Founder Rick Doblin: You’re Never Too Old For A Psychedelic Experience
Rick Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, as a “non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.”*. As a non-profit, MAPS is an unlikely player in a drug-development field dominated by big pharma and … Read More »